Osmetech tests e-nose in bacterial vaginosis trial:
This article was originally published in Clinica
UK firm Osmetech has commenced clinical trials for its "electronic nose" sensor for use in detecting bacterial vaginosis. Data obtained from the clinical trials, which will take place in both UK and US hospitals, will be used to support a US FDA marketing application, which the company expects to file by the end of April 2002. In a pre-trial study at John Hopkins Hospital, Baltimore, the bacterial vaginosis sensor gave more objective and significantly faster diagnostic readings than current testing methods, said the Crewe-based firm. The device, which detects gases emitted by bacterial metabolism, last month gained FDA approval for detection of urinary tract infections (see Clinica No 986, p 19).